1 day ago
VIENNA (AP) — Iran on Monday condemned the exclusion of the head of its Atomic Energy Organization from the annual gathering of the United Nations nuclear agency in Vienna saying that it constitutes "a serious breach" of Tehran's rights as a member nation.
"By obstructing our full and effective participation, the denial of access contravenes both the letter and the spirit of the legal framework" governing attendance at meetings of the International Atomic Energy Agency, Iran's ambassador to the agency, Reza Najafi, told delegates at its general conference.
Najafi criticized Austria, the host country of the IAEA and other U.N. organizations, saying that Vienna's decision not to grant a visa to Mohammad Eslami "violates the host country's obligation."
The Russian ambassador to the U.N. in Vienna, Mikhail Ulyanov, echoed Iran's remarks, saying that Austria had "grossly violated" its obligations as host nation of the IAEA.
Western nations had "unleashed a genuine campaign of visa-related abuses so as to settle scores with countries they deem to be undesirable," he said.
#atomic
"By obstructing our full and effective participation, the denial of access contravenes both the letter and the spirit of the legal framework" governing attendance at meetings of the International Atomic Energy Agency, Iran's ambassador to the agency, Reza Najafi, told delegates at its general conference.
Najafi criticized Austria, the host country of the IAEA and other U.N. organizations, saying that Vienna's decision not to grant a visa to Mohammad Eslami "violates the host country's obligation."
The Russian ambassador to the U.N. in Vienna, Mikhail Ulyanov, echoed Iran's remarks, saying that Austria had "grossly violated" its obligations as host nation of the IAEA.
Western nations had "unleashed a genuine campaign of visa-related abuses so as to settle scores with countries they deem to be undesirable," he said.
#atomic
11 days ago
On August 13, Kodiak Sciences Inc. (NASDAQ:KOD) reported second-quarter financial results for the period ended June 30, alongside an update on its three late-stage eye disease programs. The clinical-stage biotech told investors it now sits within months of three separate Phase 3 readouts, a stretch CEO Victor Perlroth called the payoff of years of disciplined execution. For a company with no approved products and a widening cash burn, those trial results are about to decide a lot.
Kodiak's near-term story rests on Zenkuda and KSI-501, both being tested in the Phase 3 DAYBREAK study for treatment-naive wet age-related macular degeneration, with one-year primary endpoint topline data due in September 2026. Zenkuda already has four completed Phase 3 studies behind it. In GLOW1 and GLOW2, every patient remained on extended six-month dosing at one year, and in BEACON, nearly half of Zenkuda patients needed no further treatment in the second six months while matching aflibercept on vision and anatomical outcomes. That durability comes from a mean ocular half-life of 20 days, roughly three times longer than approved anti-VEGF drugs.
Behind DAYBREAK sits PEAK, evaluating KSI-101 in macular edema secondary to inflammation, where Kodiak finished enrolling the first 300-patient cohort during the quarter and expects Pivotal ***** ysis 1 data in December 2026. Earlier Phase 1b data showed more than half of MESI patients gaining at least 15 letters of vision, with over 90% resolution of retinal fluid by week eight. Kodiak also began enrolling patients in the roughly 910-patient ALTO study testing KSI-501 against aflibercept in diabetic macular edema, its second registrational trial for that molecule. Zenkuda and KSI-501 together are aimed at a $15 billion anti-VEGF market.
None of that comes cheap. Kodiak's net loss widened to $65.6 million in the second quarter of 2026, or $1.05 per share, up from $54.3 million and $1.03 per share a year earlier. R&D spending jumped to $56.1 million from $42.8 million, as the company ramped up clinical activity across PEAK and PINNACLE and stepped up manufacturing for its Phase 3 programs. General and administrative costs eased slightly to $10.8 million from $12.8 million, but that was not enough to offset the R&D increase.
Kodiak ended the quarter with $125.9 million in cash and equivalents, which management says covers operations into 2027, but working capital fell from $169.3 million at the end of 2025 to $78.6 million by June 30, and stockholders' equity dropped from $157.4 million to $61.1 million over the same stretch. With three separate trials due to report between September and December, any delay or disappointing result would hit a balance sheet that already has less room to absorb it.
#data
Kodiak's near-term story rests on Zenkuda and KSI-501, both being tested in the Phase 3 DAYBREAK study for treatment-naive wet age-related macular degeneration, with one-year primary endpoint topline data due in September 2026. Zenkuda already has four completed Phase 3 studies behind it. In GLOW1 and GLOW2, every patient remained on extended six-month dosing at one year, and in BEACON, nearly half of Zenkuda patients needed no further treatment in the second six months while matching aflibercept on vision and anatomical outcomes. That durability comes from a mean ocular half-life of 20 days, roughly three times longer than approved anti-VEGF drugs.
Behind DAYBREAK sits PEAK, evaluating KSI-101 in macular edema secondary to inflammation, where Kodiak finished enrolling the first 300-patient cohort during the quarter and expects Pivotal ***** ysis 1 data in December 2026. Earlier Phase 1b data showed more than half of MESI patients gaining at least 15 letters of vision, with over 90% resolution of retinal fluid by week eight. Kodiak also began enrolling patients in the roughly 910-patient ALTO study testing KSI-501 against aflibercept in diabetic macular edema, its second registrational trial for that molecule. Zenkuda and KSI-501 together are aimed at a $15 billion anti-VEGF market.
None of that comes cheap. Kodiak's net loss widened to $65.6 million in the second quarter of 2026, or $1.05 per share, up from $54.3 million and $1.03 per share a year earlier. R&D spending jumped to $56.1 million from $42.8 million, as the company ramped up clinical activity across PEAK and PINNACLE and stepped up manufacturing for its Phase 3 programs. General and administrative costs eased slightly to $10.8 million from $12.8 million, but that was not enough to offset the R&D increase.
Kodiak ended the quarter with $125.9 million in cash and equivalents, which management says covers operations into 2027, but working capital fell from $169.3 million at the end of 2025 to $78.6 million by June 30, and stockholders' equity dropped from $157.4 million to $61.1 million over the same stretch. With three separate trials due to report between September and December, any delay or disappointing result would hit a balance sheet that already has less room to absorb it.
#data
13 days ago
Olivia Rodrigo leaned into edgy glamour for her latest look, pairing a skeleton micro minidress with Stuart Weitzman pumps. The "deja vu" singer turned heads at the Grammy Museum in Los Angeles, California, on September 1 for the "An Evening with Olivia Rodrigo" event. The museum's official Instagram page shared her photos from the event.
Olivia Rodrigo wore a vintage Undercover Fall/Winter 2013 Silk Skeleton Top in Orange/Black to the Grammy Museum. Styled as a micro minidress, the top featured cap sleeves and a black Peter Pan collar that rested wide across her shoulders. The garment's most eye-catching detail was the centrally printed black skeletal ribcage graphic. The goth-inspired anatomical graphic contrasted with the soft peach color of the fabric, creating a playful and edgy juxtaposition.
Styled by Chloe and Chenelle, the Grammy winner paired the lightweight dress with black sheer Wolford tights. For footwear, she opted for Stuart Weitzman Babette Patent Leather Mary Jane Pumps in black colorway. The high-shine patent finish caught the light, elevating the dark tights beneath and bringing a sleek, liquid-like **** re to her look.
The $495 shoes featured an almond-shaped toe and a slender instep strap with a metallic buckle. The 85 mm block heel elongated her frame while maintaining a retro silhouette that balanced the breezy drape of her tunic. Furthermore, its black color kept the look cohesive along her leg line.
Rodrigo wore her dark brown hair in voluminous, glossy waves parted down the side, softly framing her face. Meanwhile, her makeup was fresh and radiant. It featured a natural flush, defined lashes, and a pink lip that echoed the peach tones of her dress.
#black #rodrigo #olivia #look
Olivia Rodrigo wore a vintage Undercover Fall/Winter 2013 Silk Skeleton Top in Orange/Black to the Grammy Museum. Styled as a micro minidress, the top featured cap sleeves and a black Peter Pan collar that rested wide across her shoulders. The garment's most eye-catching detail was the centrally printed black skeletal ribcage graphic. The goth-inspired anatomical graphic contrasted with the soft peach color of the fabric, creating a playful and edgy juxtaposition.
Styled by Chloe and Chenelle, the Grammy winner paired the lightweight dress with black sheer Wolford tights. For footwear, she opted for Stuart Weitzman Babette Patent Leather Mary Jane Pumps in black colorway. The high-shine patent finish caught the light, elevating the dark tights beneath and bringing a sleek, liquid-like **** re to her look.
The $495 shoes featured an almond-shaped toe and a slender instep strap with a metallic buckle. The 85 mm block heel elongated her frame while maintaining a retro silhouette that balanced the breezy drape of her tunic. Furthermore, its black color kept the look cohesive along her leg line.
Rodrigo wore her dark brown hair in voluminous, glossy waves parted down the side, softly framing her face. Meanwhile, her makeup was fresh and radiant. It featured a natural flush, defined lashes, and a pink lip that echoed the peach tones of her dress.
#black #rodrigo #olivia #look
1 month ago
Few, if any, movie stars achieve the level of celebrity of Paul Newman without good fortune. No one recognized that more than the screen legend himself.
Newman's luck did not begin with his three-year stint in the U.S. Navy during World War II. He understood during his years in the Pacific (and then in Hollywood) that fate fell in his favor more than once.
Also Read: Why it took 2 decades for 'Patton' to make it to the big screen
While serving his country, forces beyond his control likely saved Newman's life. If a pilot in his squadron hadn't come down with an ear issue, Newman might have died at Okinawa—one of the bloodiest battles in military history. Then Newman was supposed to take part in the invasion of mainland ***** an. Dubbed Operation Downfall, Allied commanders called it off after the bombings of Hiroshima and Nagasaki.
Newman, who died on September 26, 2008, at the age of 83, admittedly didn't fully consider the potential consequences when he enlisted.
"I thought it would be a big adventure," Newman said of joining the military during wartime. "I was really dumb. I never considered that it might be dangerous."
Academy Award-winning actor Paul Newman served in the Navy for 3 years. (U.S. Navy illustration/Peggy Frierson)
Born on January 26, 1925, in Ohio, Newman was in his first year at Ohio University when he dropped out. Newman signed up for the Navy with the intent of becoming a pilot. He never made it to the ***** pit after a supposedly routine exam revealed he was colorblind.
Newman pivoted from that diagnosis and began training as a rear gunner and radioman for Grumman TBF Avenger torpedo bombers. In the Pacific, the Navy ***** igned Newman to squadrons that trained air crews and pilots. After a stint as a turret gunner, the plan was for Newman and his squadron to meet up with the USS Bunker Hill, an aircraft carrier stationed near the shore of Okinawa.
They never made it that far after their pilot wasn't medically cleared to fly. That turned out to be a likely life-saver after the ***** anese unleashed kamikaze attacks on the USS Bunker Hill on May 11, 1945. Nearly 400 men on the carrier died, with 264 more wounded.
It wasn't the only time that Newman, then only 20 years old, skirted death during the war. He did it again a few months later. When the United States dropped an atomic bomb on Hiroshima on August 6, 1945, Newman was on an aircraft carrier several hundred miles from ***** an. Three days later, another bomb destroyed Nagasaki.
Approximately 214,000 ***** anese citizens, including roughly 38,000 children, died in the attacks, per the International Campaign to Abolish Nuclear Weapons (ICAN). Those numbers don't include those who were maimed. While President Harry S. Truman's decision remains a source of debate, but Newman didn't question it.
"I know all of the controversy about those weapons," Newman said. "But I'm one of those guys who says, 'Thank God for the atomic bomb,' because it pro
Newman's luck did not begin with his three-year stint in the U.S. Navy during World War II. He understood during his years in the Pacific (and then in Hollywood) that fate fell in his favor more than once.
Also Read: Why it took 2 decades for 'Patton' to make it to the big screen
While serving his country, forces beyond his control likely saved Newman's life. If a pilot in his squadron hadn't come down with an ear issue, Newman might have died at Okinawa—one of the bloodiest battles in military history. Then Newman was supposed to take part in the invasion of mainland ***** an. Dubbed Operation Downfall, Allied commanders called it off after the bombings of Hiroshima and Nagasaki.
Newman, who died on September 26, 2008, at the age of 83, admittedly didn't fully consider the potential consequences when he enlisted.
"I thought it would be a big adventure," Newman said of joining the military during wartime. "I was really dumb. I never considered that it might be dangerous."
Academy Award-winning actor Paul Newman served in the Navy for 3 years. (U.S. Navy illustration/Peggy Frierson)
Born on January 26, 1925, in Ohio, Newman was in his first year at Ohio University when he dropped out. Newman signed up for the Navy with the intent of becoming a pilot. He never made it to the ***** pit after a supposedly routine exam revealed he was colorblind.
Newman pivoted from that diagnosis and began training as a rear gunner and radioman for Grumman TBF Avenger torpedo bombers. In the Pacific, the Navy ***** igned Newman to squadrons that trained air crews and pilots. After a stint as a turret gunner, the plan was for Newman and his squadron to meet up with the USS Bunker Hill, an aircraft carrier stationed near the shore of Okinawa.
They never made it that far after their pilot wasn't medically cleared to fly. That turned out to be a likely life-saver after the ***** anese unleashed kamikaze attacks on the USS Bunker Hill on May 11, 1945. Nearly 400 men on the carrier died, with 264 more wounded.
It wasn't the only time that Newman, then only 20 years old, skirted death during the war. He did it again a few months later. When the United States dropped an atomic bomb on Hiroshima on August 6, 1945, Newman was on an aircraft carrier several hundred miles from ***** an. Three days later, another bomb destroyed Nagasaki.
Approximately 214,000 ***** anese citizens, including roughly 38,000 children, died in the attacks, per the International Campaign to Abolish Nuclear Weapons (ICAN). Those numbers don't include those who were maimed. While President Harry S. Truman's decision remains a source of debate, but Newman didn't question it.
"I know all of the controversy about those weapons," Newman said. "But I'm one of those guys who says, 'Thank God for the atomic bomb,' because it pro
1 month ago
After nearly two hours in stop-and-go traffic on a one-lane coastal road, we decided to call it. Dogs joyfully poking their heads out of car windows was the closest my husband and I got to the World Dog Surfing Championships this year.
My husband and I have been attending this annual dog surfing event in Pacifica, California, every summer, but this year—the championship's 10th anniversary—was its biggest yet. As talented surfing dogs, including the event's winner, a Yellow Labrador named Rippin' Rosie Drottar, took over the beach, thousands of dog enthusiasts just like us flocked to the coast for a chance to get a peek. The tiny beach town nearly shut down with the crowds!
Everyone wanted to watch these dogs hang ten! (Or, hang 18, if you want to be anatomically correct.) The event featured 14 talented pups of all sizes competing for 7 categories, including solo surfing (small, medium, and large), human-dog tandem surfing, dog-dog tandem surfing, stand-up paddleboarding, and an overall championship.
Even though the experienced surfing dogs like Iza the French Bulldog put on a show for those who were lucky enough to get to the beach, some pups didn't get to ride as many waves as planned. The competition continued despite rough surf, but several of the later heats were canceled in order to keep surfers safe.
"It was rough," contestant Sophia Sadlowski told KQED. "A little too rough for that size dog. Yeah, I mean it's rough for the other dogs, but when you're 12 pounds, it's just too much." Her dog, 'Rusty the Surfing MinPin,' still took home 3rd place in the small dog category and 1st place alongside Iza in the dog/dog tandem category, but one special Yellow Labrador took home more awards than any other pooch.
#Surfing #dogs
My husband and I have been attending this annual dog surfing event in Pacifica, California, every summer, but this year—the championship's 10th anniversary—was its biggest yet. As talented surfing dogs, including the event's winner, a Yellow Labrador named Rippin' Rosie Drottar, took over the beach, thousands of dog enthusiasts just like us flocked to the coast for a chance to get a peek. The tiny beach town nearly shut down with the crowds!
Everyone wanted to watch these dogs hang ten! (Or, hang 18, if you want to be anatomically correct.) The event featured 14 talented pups of all sizes competing for 7 categories, including solo surfing (small, medium, and large), human-dog tandem surfing, dog-dog tandem surfing, stand-up paddleboarding, and an overall championship.
Even though the experienced surfing dogs like Iza the French Bulldog put on a show for those who were lucky enough to get to the beach, some pups didn't get to ride as many waves as planned. The competition continued despite rough surf, but several of the later heats were canceled in order to keep surfers safe.
"It was rough," contestant Sophia Sadlowski told KQED. "A little too rough for that size dog. Yeah, I mean it's rough for the other dogs, but when you're 12 pounds, it's just too much." Her dog, 'Rusty the Surfing MinPin,' still took home 3rd place in the small dog category and 1st place alongside Iza in the dog/dog tandem category, but one special Yellow Labrador took home more awards than any other pooch.
#Surfing #dogs
2 months ago
This story was originally published on Banking Dive. To receive daily news and insights, subscribe to our free daily Banking Dive newsletter.
Chime is adding an investment product to its ******* nal.
The fintech launched Chime Invest on its app, allowing users to buy stocks and exchange-traded funds commission-free, the company announced Monday.
Alternately, customers can choose to let Chime partner Atomic Invest create a portfolio tailored to their goals and risk profile, with no account balance minimum and no fees if they are Chime Prime members.
Chime unveiled a tiered membership structure in April. The managed portfolio option in Chime Invest comes with a 0.10% annual fee for users in the fintech's second tier, Chime Plus. Other Chime members would pay a 0.25% annual management fee for the service.
#chime #Invest #banking #Portfolio
Chime is adding an investment product to its ******* nal.
The fintech launched Chime Invest on its app, allowing users to buy stocks and exchange-traded funds commission-free, the company announced Monday.
Alternately, customers can choose to let Chime partner Atomic Invest create a portfolio tailored to their goals and risk profile, with no account balance minimum and no fees if they are Chime Prime members.
Chime unveiled a tiered membership structure in April. The managed portfolio option in Chime Invest comes with a 0.10% annual fee for users in the fintech's second tier, Chime Plus. Other Chime members would pay a 0.25% annual management fee for the service.
#chime #Invest #banking #Portfolio
2 months ago
Look, everyone, you need to come to grips with the reality that Indiana really did win the College Football Playoff National Championship under Curt Cignetti, and it might do it again.
This isn't stopping.
Anecdotal, I know, but let me sum up the prevailing attitude of just about all the various media hits I've done since the Hoosiers had, arguably, the greatest season in the history of college football.
Wonderful story, amazing job done by Cignetti. Now Ohio State, Alabama, Notre Dame, and the other bluebloods will restore order, and Indiana will go back to waiting for basketball season.
Well done, Hoosiers, here are your commemorative t-shirts, off you go ...
Nope.
Grace Hollars/IndyStar / USA TODAY NETWORK via Imagn Images
It's not just that Indiana took a blowtorch to everything the stodgy world of college football knows to be holy, right, and true.
It's that now everyone - from Kentucky to UCLA to insert-your-Power-Four-school-here - has some glimmer of hope that maybe, with the right mix of miracles, can have the type of success that fans of most schools have been generationally conditioned to not dare dream possible.
It's also that the bar has been raised for the powerhouses.
Alabama didn't just lose in the College Football Playoff. Ala-FREAKING-Bama is still recovering from the atomic wedgie applied by ... Indiana?! It offends the sensibilities.
And if you think that's not sitting well for an Alabama, try Nebraska, and USC, and Florida and all the other traditional football schools that expect to compete for giant things every year, and can't.
But no, this doesn't necessarily mean Indiana will win the national ****** le again this year, or next year, or five years from now. It means that it'll at least be in the mix.
Ohio State doesn't win it all every year. Texas still hasn't won one since Vince Young. Notre Dame hasn't won one since 1988.
#alabama #done #playoff
This isn't stopping.
Anecdotal, I know, but let me sum up the prevailing attitude of just about all the various media hits I've done since the Hoosiers had, arguably, the greatest season in the history of college football.
Wonderful story, amazing job done by Cignetti. Now Ohio State, Alabama, Notre Dame, and the other bluebloods will restore order, and Indiana will go back to waiting for basketball season.
Well done, Hoosiers, here are your commemorative t-shirts, off you go ...
Nope.
Grace Hollars/IndyStar / USA TODAY NETWORK via Imagn Images
It's not just that Indiana took a blowtorch to everything the stodgy world of college football knows to be holy, right, and true.
It's that now everyone - from Kentucky to UCLA to insert-your-Power-Four-school-here - has some glimmer of hope that maybe, with the right mix of miracles, can have the type of success that fans of most schools have been generationally conditioned to not dare dream possible.
It's also that the bar has been raised for the powerhouses.
Alabama didn't just lose in the College Football Playoff. Ala-FREAKING-Bama is still recovering from the atomic wedgie applied by ... Indiana?! It offends the sensibilities.
And if you think that's not sitting well for an Alabama, try Nebraska, and USC, and Florida and all the other traditional football schools that expect to compete for giant things every year, and can't.
But no, this doesn't necessarily mean Indiana will win the national ****** le again this year, or next year, or five years from now. It means that it'll at least be in the mix.
Ohio State doesn't win it all every year. Texas still hasn't won one since Vince Young. Notre Dame hasn't won one since 1988.
#alabama #done #playoff
2 months ago
Lam Research Corporation (NASDAQ:LRCX) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday's market rotation. Cramer mentioned the stock during the episode and said:
Oh, how about the semiconductor capital equipment makers? Oh, did I ever know them well. I've been adamant that these companies own a huge amount of intellectual property. They're the answers to the production needs of the Microns, the Seagates of the world, but did the Trust buy Applied Materials? Did it pick up some Lam Research? Did it even scrutinize KLA, all of which were on the show? No. I kept waiting and waiting for a break in their stocks, a break that never came. I whiffed.
Photo by Yiorgos Ntrahas on Unsplash
Lam Research Corporation (NASDAQ:LRCX) develops equipment for depositing, etching, and cleaning semiconductor materials. It includes systems for tungsten and copper metallization, plasma and atomic-layer deposition, dielectric and conductor etch, and wafer cleaning. When a caller inquired about the stock during the March 20 episode, Cramer replied:
Oh yeah, yeah, yeah, yeah. I agree. Lam is the winner of what happened in Micron. People didn't seem to notice. You buy, if you had to buy 100 shares, you buy 50 on Monday, okay? And then you wait, down 10%, and you buy another 50. You've got a winner in Lam Research.
Oh, how about the semiconductor capital equipment makers? Oh, did I ever know them well. I've been adamant that these companies own a huge amount of intellectual property. They're the answers to the production needs of the Microns, the Seagates of the world, but did the Trust buy Applied Materials? Did it pick up some Lam Research? Did it even scrutinize KLA, all of which were on the show? No. I kept waiting and waiting for a break in their stocks, a break that never came. I whiffed.
Photo by Yiorgos Ntrahas on Unsplash
Lam Research Corporation (NASDAQ:LRCX) develops equipment for depositing, etching, and cleaning semiconductor materials. It includes systems for tungsten and copper metallization, plasma and atomic-layer deposition, dielectric and conductor etch, and wafer cleaning. When a caller inquired about the stock during the March 20 episode, Cramer replied:
Oh yeah, yeah, yeah, yeah. I agree. Lam is the winner of what happened in Micron. People didn't seem to notice. You buy, if you had to buy 100 shares, you buy 50 on Monday, okay? And then you wait, down 10%, and you buy another 50. You've got a winner in Lam Research.
2 months ago
Lam Research Corporation (NASDAQ:LRCX) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday's market rotation. Cramer mentioned the stock during the episode and said:
Oh, how about the semiconductor capital equipment makers? Oh, did I ever know them well. I've been adamant that these companies own a huge amount of intellectual property. They're the answers to the production needs of the Microns, the Seagates of the world, but did the Trust buy Applied Materials? Did it pick up some Lam Research? Did it even scrutinize KLA, all of which were on the show? No. I kept waiting and waiting for a break in their stocks, a break that never came. I whiffed.
Photo by Yiorgos Ntrahas on Unsplash
Lam Research Corporation (NASDAQ:LRCX) develops equipment for depositing, etching, and cleaning semiconductor materials. It includes systems for tungsten and copper metallization, plasma and atomic-layer deposition, dielectric and conductor etch, and wafer cleaning. When a caller inquired about the stock during the March 20 episode, Cramer replied:
Oh yeah, yeah, yeah, yeah. I agree. Lam is the winner of what happened in Micron. People didn't seem to notice. You buy, if you had to buy 100 shares, you buy 50 on Monday, okay? And then you wait, down 10%, and you buy another 50. You've got a winner in Lam Research.
Oh, how about the semiconductor capital equipment makers? Oh, did I ever know them well. I've been adamant that these companies own a huge amount of intellectual property. They're the answers to the production needs of the Microns, the Seagates of the world, but did the Trust buy Applied Materials? Did it pick up some Lam Research? Did it even scrutinize KLA, all of which were on the show? No. I kept waiting and waiting for a break in their stocks, a break that never came. I whiffed.
Photo by Yiorgos Ntrahas on Unsplash
Lam Research Corporation (NASDAQ:LRCX) develops equipment for depositing, etching, and cleaning semiconductor materials. It includes systems for tungsten and copper metallization, plasma and atomic-layer deposition, dielectric and conductor etch, and wafer cleaning. When a caller inquired about the stock during the March 20 episode, Cramer replied:
Oh yeah, yeah, yeah, yeah. I agree. Lam is the winner of what happened in Micron. People didn't seem to notice. You buy, if you had to buy 100 shares, you buy 50 on Monday, okay? And then you wait, down 10%, and you buy another 50. You've got a winner in Lam Research.
2 months ago
Johnson & Johnson (NYSE:JNJ) is one of billionaire Cliff Asness' top 10 healthcare stock picks. On June 25, Johnson & Johnson (NYSE:JNJ) announced the commercial launch of the Dual Energy THERMOCOOL SMARTTOUCH SF (DE STSF) Platform in Europe. That means the platform is now commercially available to electrophysiologists across the EMEA region for the treatment of cardiac arrhythmias, including atrial fibrillation.
Copyright: moovstock / 123RF Stock Photo
The company said that the platform is the first of its kind to combine two distinct energy sources in a single catheter-based solution. It combines radiofrequency (RF) and pulsed field (PF) energy to allow physicians to switch between the two during the same procedure without having to change equipment. This is clinically significant because RF and PF ablation each have different tissue effects and safety profiles, said Nicolas Derval, M.D., a consultant for Johnson & Johnson based in Bordeaux, France. Derval added that the ability to use both gives doctors more flexibility to tailor treatment to individual patient anatomy and disease patterns.
Johnson & Johnson explained that the platform consists of the DE STSF Catheter, which is an irrigated, contact-force sensing catheter that physically delivers energy to heart tissue. The other half consists of the TRUPULSE Generator, which controls and powers the delivery of both RF and PF energy. The company said the system is fully integrated with its CARTO 3 System, which is an electro-anatomical mapping platform. This combination enables real-time 3D visualization, contact-force feedback, and index-guided ablation during live procedures.
Johnson & Johnson (NYSE:JNJ) is a healthcare conglomerate. It operates through two segments: Innovative Medicine, which develops and markets prescription drugs in oncology, immunology, neuroscience, and infectious disease, and MedTech, which manufactures medical devices for surgery, orthopedics, and interventional solutions.
Copyright: moovstock / 123RF Stock Photo
The company said that the platform is the first of its kind to combine two distinct energy sources in a single catheter-based solution. It combines radiofrequency (RF) and pulsed field (PF) energy to allow physicians to switch between the two during the same procedure without having to change equipment. This is clinically significant because RF and PF ablation each have different tissue effects and safety profiles, said Nicolas Derval, M.D., a consultant for Johnson & Johnson based in Bordeaux, France. Derval added that the ability to use both gives doctors more flexibility to tailor treatment to individual patient anatomy and disease patterns.
Johnson & Johnson explained that the platform consists of the DE STSF Catheter, which is an irrigated, contact-force sensing catheter that physically delivers energy to heart tissue. The other half consists of the TRUPULSE Generator, which controls and powers the delivery of both RF and PF energy. The company said the system is fully integrated with its CARTO 3 System, which is an electro-anatomical mapping platform. This combination enables real-time 3D visualization, contact-force feedback, and index-guided ablation during live procedures.
Johnson & Johnson (NYSE:JNJ) is a healthcare conglomerate. It operates through two segments: Innovative Medicine, which develops and markets prescription drugs in oncology, immunology, neuroscience, and infectious disease, and MedTech, which manufactures medical devices for surgery, orthopedics, and interventional solutions.
3 months ago
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the best fast growth stocks to buy according to hedge funds. On June 8, Advanced Micro Devices, Inc.'s (NASDAQ:AMD) Chair and CEO, Dr. Lisa Su, announced the company's commitment to invest up to £2 billion over the next five years in the United Kingdom. Dr. Su made the announcement on the first day of London Tech Week, which took place from June 8 to June 12.
The investment will be made in chunks where there will be a package for infrastructure deployments, research collaborations, and ecosystem partnerships. All these investments, said Dr. Su, will be centered on AMD's Instinct GPUs, EPYC CPUs, and ROCm open software. These are the three pillars of AMD's AI compute stack.
The CEO detailed that AMD, together with Dell Technologies, is already collaborating with the University of Cambridge to expand its national AI infrastructure footprint. This includes supporting the new Zenith AI supercomputer. The supercomputer is a major UK AI-for-science platform funded by the Department for Science, Innovation and Technology (DSIT) and UK Research and Innovation (UKRI). It is designed to serve a broad range of scientific disciplines like healthcare research, climate modeling, materials science, and engineering simulation.
The two companies are also building the Sunrise fusion AI system, which is a second AI supercomputer at Cambridge. This one is funded by the Department for Energy Security and Net Zero, owned by the UK Atomic Energy Authority (UKAEA). Sunrise is dedicated exclusively to the fusion energy mission.
Advanced Micro Devices, Inc. (NASDAQ:AMD) is a semiconductor company. It designs and sells microprocessors, GPUs, and adaptive system-on-chip products for data centers, personal computers, gaming, and embedded markets.
The investment will be made in chunks where there will be a package for infrastructure deployments, research collaborations, and ecosystem partnerships. All these investments, said Dr. Su, will be centered on AMD's Instinct GPUs, EPYC CPUs, and ROCm open software. These are the three pillars of AMD's AI compute stack.
The CEO detailed that AMD, together with Dell Technologies, is already collaborating with the University of Cambridge to expand its national AI infrastructure footprint. This includes supporting the new Zenith AI supercomputer. The supercomputer is a major UK AI-for-science platform funded by the Department for Science, Innovation and Technology (DSIT) and UK Research and Innovation (UKRI). It is designed to serve a broad range of scientific disciplines like healthcare research, climate modeling, materials science, and engineering simulation.
The two companies are also building the Sunrise fusion AI system, which is a second AI supercomputer at Cambridge. This one is funded by the Department for Energy Security and Net Zero, owned by the UK Atomic Energy Authority (UKAEA). Sunrise is dedicated exclusively to the fusion energy mission.
Advanced Micro Devices, Inc. (NASDAQ:AMD) is a semiconductor company. It designs and sells microprocessors, GPUs, and adaptive system-on-chip products for data centers, personal computers, gaming, and embedded markets.
3 months ago
By Tala Ramadan and Nayera Abdallah
DUBAI, June 23 (Reuters) - The United States waived sanctions on Iran for 60 days from Monday after the first talks under a nascent peace deal, with U.S. President Donald Trump saying he will "do what I have to do" if Iran does not stick to its side of the agreement.
U.S. Vice President JD Vance said talks with Iranian officials in Switzerland had laid a good foundation for a final peace deal, but Iran denied it had begun discussions on its nuclear program or agreed to invite International Atomic Energy Agency inspectors back to the country.
Foreign Ministry spokesperson Esmail Baghaei said on Tuesday Iranian officials had not held a meeting with IAEA chief Rafael Grossi in Switzerland and had no plans for the U.N. nuclear watchdog to inspect Iran's damaged nuclear facilities.
The two sides, trying to build on the interim deal they signed last week after more than three months of war, agreed a roadmap towards a permanent agreement within 60 days at the talks in the Swiss mountain resort of Buergenstock, mediators Pakistan and Qatar said.
DUBAI, June 23 (Reuters) - The United States waived sanctions on Iran for 60 days from Monday after the first talks under a nascent peace deal, with U.S. President Donald Trump saying he will "do what I have to do" if Iran does not stick to its side of the agreement.
U.S. Vice President JD Vance said talks with Iranian officials in Switzerland had laid a good foundation for a final peace deal, but Iran denied it had begun discussions on its nuclear program or agreed to invite International Atomic Energy Agency inspectors back to the country.
Foreign Ministry spokesperson Esmail Baghaei said on Tuesday Iranian officials had not held a meeting with IAEA chief Rafael Grossi in Switzerland and had no plans for the U.N. nuclear watchdog to inspect Iran's damaged nuclear facilities.
The two sides, trying to build on the interim deal they signed last week after more than three months of war, agreed a roadmap towards a permanent agreement within 60 days at the talks in the Swiss mountain resort of Buergenstock, mediators Pakistan and Qatar said.
3 months ago
DUBAI, United Arab Emirates (AP) — Israeli Prime Minister Benjamin Netanyahu has claimed that Iran would have developed a nuclear weapon and used it on Israel were it not for the two recent wars. There is no public evidence for that ***** sment, which runs counter to those of the U.N. nuclear watchdog and U.S. intelligence agencies.
For decades, Netanyahu has made dire predictions about Iran's disputed nuclear program, most famously at the United Nations with visual aids. The rhetoric has escalated since the U.S. and Iran reached an interim peace deal this month, and as Netanyahu faces elections later this year.
Iran has always insisted its nuclear program is peaceful, even as it has enriched uranium to near-weapons-grade levels far higher than those required for civilian use. The United States and others say Iran's nuclear program had a military component until 2003.
Even before the two wars set back its nuclear program, Iran was months or years away from developing a usable atomic weapon, and there's no evidence it had chosen to pursue one. Israel is widely believed to have its own nuclear weapons.
Here's a closer look.
For decades, Netanyahu has made dire predictions about Iran's disputed nuclear program, most famously at the United Nations with visual aids. The rhetoric has escalated since the U.S. and Iran reached an interim peace deal this month, and as Netanyahu faces elections later this year.
Iran has always insisted its nuclear program is peaceful, even as it has enriched uranium to near-weapons-grade levels far higher than those required for civilian use. The United States and others say Iran's nuclear program had a military component until 2003.
Even before the two wars set back its nuclear program, Iran was months or years away from developing a usable atomic weapon, and there's no evidence it had chosen to pursue one. Israel is widely believed to have its own nuclear weapons.
Here's a closer look.
3 months ago
The scientists have been right about climate change all along, says former Vice President Al Gore on the 20th anniversary of the release of "An Inconvenient Truth," the Oscar-winning documentary about Gore's campaign to educate people about climate change.
When asked by ABC News chief meteorologist and chief climate correspondent Ginger Zee whether the film and its predictions on global warming hold up, Gore responded, "Unfortunately, yes."
"The scientists were dead right on all the important elements of it, and it really is insane that we are continuing to use the sky as an open sewer and we're trapping so much heat every day it's equal to the amount that would be released by 800,000 Hiroshima-class atomic bombs exploding every day on the earth," Gore said during an interview with ABC News at his family farm in Tennessee.
Solar generates more energy than coal in US for 1st time: Report
In a review of key claims by the documentary, ABC News found that the majority of the scientific observations made in "An Inconvenient Truth" have come to fruition or are on track to in the years to come. The last 11 years -- from 2015 to 2025 -- have been the hottest on record, according to scientific data from NOAA and the Copernicus Climate Change Service and summarized in a report released earlier this year by the World Meteorological Organization.
When asked by ABC News chief meteorologist and chief climate correspondent Ginger Zee whether the film and its predictions on global warming hold up, Gore responded, "Unfortunately, yes."
"The scientists were dead right on all the important elements of it, and it really is insane that we are continuing to use the sky as an open sewer and we're trapping so much heat every day it's equal to the amount that would be released by 800,000 Hiroshima-class atomic bombs exploding every day on the earth," Gore said during an interview with ABC News at his family farm in Tennessee.
Solar generates more energy than coal in US for 1st time: Report
In a review of key claims by the documentary, ABC News found that the majority of the scientific observations made in "An Inconvenient Truth" have come to fruition or are on track to in the years to come. The last 11 years -- from 2015 to 2025 -- have been the hottest on record, according to scientific data from NOAA and the Copernicus Climate Change Service and summarized in a report released earlier this year by the World Meteorological Organization.
3 months ago
SEOUL, June 4 (Reuters) - North Korean leader Kim Jong Un visited a newly operational nuclear material production facility and called for an "exponential" expansion of the country's atomic ***** nal, state media KCNA said on Thursday.
Kim said production capacity for weapons-grade nuclear material had reached more than double its previous level over the past five years and instructed officials to further increase output to meet long-term strategic goals.
During the visit, Kim was briefed on new production processes incorporating more advanced technology and reviewed current output targets and future plans, KCNA reported.
Kim said the expansion was necessary given what he called worsening security threats and long-term confrontation with hostile forces, and reaffirmed the country’s policy of continuously increasing its nuclear deterrent.
KCNA said a key consultative meeting on bolstering nuclear forces was held the same day, at which Kim outlined guidelines for accelerating both the qualitative and quantitative expansion of North Korea’s nuclear ***** nal.
Kim said production capacity for weapons-grade nuclear material had reached more than double its previous level over the past five years and instructed officials to further increase output to meet long-term strategic goals.
During the visit, Kim was briefed on new production processes incorporating more advanced technology and reviewed current output targets and future plans, KCNA reported.
Kim said the expansion was necessary given what he called worsening security threats and long-term confrontation with hostile forces, and reaffirmed the country’s policy of continuously increasing its nuclear deterrent.
KCNA said a key consultative meeting on bolstering nuclear forces was held the same day, at which Kim outlined guidelines for accelerating both the qualitative and quantitative expansion of North Korea’s nuclear ***** nal.
9 months ago
Startups will soon be ready to demonstrate how they make nuclear fusion work, but a lot of obstacles are in their way.
Could the end of the energy crisis be in sight?
"Creating a working star on Earth might sound flat-out impossible, had scientists not already gone so far toward doing it," The New York Times reported as multiple startups are looking to get fusion out of laboratories.
Fusion is the thermonuclear reaction that occurs in the core of stars, including the sun. But why all the hype around it?
As the International Atomic Energy Agency explains it, "if nuclear fusion can be replic
Could the end of the energy crisis be in sight?
"Creating a working star on Earth might sound flat-out impossible, had scientists not already gone so far toward doing it," The New York Times reported as multiple startups are looking to get fusion out of laboratories.
Fusion is the thermonuclear reaction that occurs in the core of stars, including the sun. But why all the hype around it?
As the International Atomic Energy Agency explains it, "if nuclear fusion can be replic
10 months ago
'The cross I've carried': Nagasaki atomic bomb survivors share experiences in New Mexico
Dec. 3—On Aug. 9, 1945, 6-year-old Chiyoko Motomura was playing on a veranda at her family's Nagasaki, ***** an, home. Her mother, aunt and grandfather were weeding the rice fields while her grandmother was preparing lunch when they heard a lightning-like crack.
"Bachiiiiing!" Motomura, now 86, said through a translated PowerPoint presentation at the University of New Mexico's Zimmerman Library on Wednesday. "A bright flash of light exploded in front of my eyes ... and with a loud thud my small body wa
Dec. 3—On Aug. 9, 1945, 6-year-old Chiyoko Motomura was playing on a veranda at her family's Nagasaki, ***** an, home. Her mother, aunt and grandfather were weeding the rice fields while her grandmother was preparing lunch when they heard a lightning-like crack.
"Bachiiiiing!" Motomura, now 86, said through a translated PowerPoint presentation at the University of New Mexico's Zimmerman Library on Wednesday. "A bright flash of light exploded in front of my eyes ... and with a loud thud my small body wa
10 months ago
Scientists in the U.K. have achieved a major breakthrough — a key step in unlocking greener, nearly limitless energy.
The Times reported that researchers at the U.K. Atomic Energy Authority successfully used small magnetic coils to stabilize the edge of the superheated plasma inside their apple-shaped Mega Amp Spherical Tokamak Upgrade.
Fusion energy is the same reaction that powers the sun. It works by merging or fusing two lighter atoms, like hydrogen atoms, to form a heavier atom, like helium. It releases enormous energy in the process.
Unlike fission reactions, fusion produces minimal l
The Times reported that researchers at the U.K. Atomic Energy Authority successfully used small magnetic coils to stabilize the edge of the superheated plasma inside their apple-shaped Mega Amp Spherical Tokamak Upgrade.
Fusion energy is the same reaction that powers the sun. It works by merging or fusing two lighter atoms, like hydrogen atoms, to form a heavier atom, like helium. It releases enormous energy in the process.
Unlike fission reactions, fusion produces minimal l
1 yr. ago
Trump elogia a Irán y dice que es un país hermoso, y líderes fuertes y están dispuestos a trabajar con EEUU, habrá paz en Medio Oriente. Quedaron 2 instalaciones nucleares que solo las puede destruir EE.UU si hacen paz volveran a enriquecer uranio y tener bomba atomica.
#Israel
#Israel
1 yr. ago
University of Michigan, Lakka, Valar Atomics, Navitas Semiconductor. Read this week's ceramic and glass business news of the week for June 2, 2025. https://ceramics.org/ceram...
https://ceramics.org/ceram...
https://ceramics.org/ceram...
